ArticleThe New England journal of medicine2016
Engineering Reversal - Finding an Antidote for Direct Oral Anticoagulants.
Article in The New England journal of medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- The anticoagulant effects of milvexian, a novel small molecule factor XIa inhibitor, are neutralized by activated prothrombin complex concentrates and recombinant factor VIIa in human plasma and whole bloodResearch and practice in thrombosis and haemostasis · 2024Article
- Article
- Direct oral anticoagulants: a review on the current role and scope of reversal agents.Journal of thrombosis and thrombolysis · 2020Review
- Spontaneous splenic rupture due to rivaroxaban.BMJ case reports · 2018Article
- Management of Factor Xa inhibitor-associated life-threatening major hemorrhage: A retrospective multi-center analysis.The American journal of emergency medicine · 2018Article
- Reversing factor Xa inhibitors - clinical utility of andexanet alfa.Journal of blood medicine · 2017Review
- [Comment on: Andexanet alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.]Der Anaesthesist · 2016Article
Corrections and comments
- Commented on by
- Commented on by
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
27653570What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.